% !TEX root = MAIN.tex

\section{Responses to ESA comments provided on 03.03.2020}
\label{sec:ESA:comments:1}


\setlength\LTleft{0pt}
\setlength\LTright{0pt}
\tiny 
%@{\extracolsep{\fill}}
\begin{longtable}{|p{1.5cm}|p{12cm}|@{}}
%\caption{\normalsize .}
\label{table:comments:responses} 
\textbf{Comment ID}&\textbf{Response}\\
\\
\hline
CSR-PABG-1&
\begin{minipage}{12cm}
\TODO{}
\end{minipage}\\
\\
\hline

%To generate the table:
%x=2;while [ $x -lt 54 ];do echo "CSR-PABG-$x&"; echo "\begin{minipage}{12cm}"; echo "\end{minipage}\\"; echo "\\"; echo "\hline"; x=$(($x+1)); done
%echo "CSR-PABG-$x&"; echo "\begin{minipage}{12cm}"; echo "\end{minipage}\\"; echo "\hline"

CSR-PABG-2&
\begin{minipage}{12cm}
\TODO{}
\end{minipage}\\
\hline
CSR-PABG-3&
\begin{minipage}{12cm}
Done.
\end{minipage}\\
\hline
CSR-PABG-4&
\begin{minipage}{12cm}
\TODO{}
\end{minipage}\\
\hline
CSR-PABG-5&
\begin{minipage}{12cm}
\TODO{}
\end{minipage}\\
\hline
CSR-PABG-6&
\begin{minipage}{12cm}
Sorry for that. We rephrased a couple of sentences in that section.
\end{minipage}\\
\hline
CSR-PABG-7&
\begin{minipage}{12cm}
The definition appears in D1 Section 1.2.5.
\end{minipage}\\
\hline
CSR-PABG-8&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-9&
\begin{minipage}{12cm}
Yes, we have defined a RQ to evaluate SDL alone.
\end{minipage}\\
\hline
CSR-PABG-10&
\begin{minipage}{12cm}
Compile time optimizations appear not to be necessary if a smart compilation process is in place. Basicaly, the compilation routine that we propose (i.e., copy the mutated file inside a compiled source tree) is somehow an optmization.
\end{minipage}\\
\hline
CSR-PABG-11&
\begin{minipage}{12cm}
We addressed in the text. Section~\ref{sec:codemutation:evaluation}.
\end{minipage}\\
\hline
CSR-PABG-12&
\begin{minipage}{12cm}
\TODO{Oscar :)}
\end{minipage}\\
\hline
CSR-PABG-13&
\begin{minipage}{12cm}
We agree. For FAQAS, we are already addressing the problem of collecting fine-grained code coverage for ESAL (there is no filesystem thus gcov needs to be combined with gdb, according to guidelines from Thanassis Tsiodras at https://www.thanassis.space/coverage.html). To address the comment, we included the research questions RQ7 and RQ9.
\end{minipage}\\
\hline
CSR-PABG-14&
\begin{minipage}{12cm}
We did a mistake when copying files from an ongoing paper. Now Table~\ref{table:operators} is in line with the rest.
\end{minipage}\\
\hline
CSR-PABG-15&
\begin{minipage}{12cm}
We addressed the comment in Step 4 and in RQ1.
\end{minipage}\\
\hline
CSR-PABG-16&
\begin{minipage}{12cm}
RQ2 address this question.
\end{minipage}\\
\hline
CSR-PABG-17&
\begin{minipage}{12cm}
We rewrote line 1 to clarify where t comes from.
We clarified the rest in the text.
\end{minipage}\\
\hline
CSR-PABG-18&
\begin{minipage}{12cm}
Since these distances have nothing to do with mutation testing but it is part of our contribution, we prefer to not add to D1 (we would not have an appropriate section for them). If necessary we can provide additional description in D2.
\end{minipage}\\
\hline
CSR-PABG-19&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-20&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-21&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-22&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-23&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-24&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-25&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-26&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-27&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-28&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-29&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-30&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-31&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-32&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-33&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-34&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-35&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-36&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-37&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-38&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-39&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-40&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-41&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-42&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-43&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-44&
\begin{minipage}{12cm}
We added a brief description in Section~\ref{sec:caseStudies:GSL:libgcsp} about the test framework, test suite and HPC configuration used in the GSL case studies.
\end{minipage}\\
\hline
CSR-PABG-45&
\begin{minipage}{12cm}
We clarified in Section~\ref{sec:caseStudies:GSL:libgcsp} that the use case libgscsp is covering integration testing.
\end{minipage}\\
\hline
CSR-PABG-46&
\begin{minipage}{12cm}

\begin{itemize}
	\item We should be assessing a test suite as a whole, and if some statements are not covered, this is already a sign that the test suite may not be complete enough. 
	
	The point is that if a statement is not covered by the test suite, there is absolutely no chance that a mutant generated in the non-covered statement can be possibly detected by any test case (see \INDEX{killing conditions} of a mutant in D1 Section 1.3.1). For this reason, we make the assumption that test suites are of high quality standards, and therefore, we consider only the covered statements.

	\item When computing the mutation score, is it fare to not count those not-covered lines?

	Yes, is it fare because mutation testing assess the quality of existing test suites, and considering non-covered statements would be out of the scope of the technique. Also, including non-covered statements into the mutation score, would not let us to assess correctly the quality of the existing test suite.

  	\item Maybe the approach would be to run the test augmentation process to provide test cases for the missing statements??

	\TODO{I think the literature does not cover this issue}
	I think this is not possible, because we would be missing the test oracle.  Also, in that case, we would be assessing through mutation testing the quality of the test augmentation process instead of the quality of the existing test suite.

\end{itemize}
\end{minipage}\\
\hline
CSR-PABG-47&
\begin{minipage}{12cm}
We clarified the scope of our analysis for the case study libgscsp in Section~\ref{sec:caseStudies:GSL:libgcsp}. 
\end{minipage}\\
\hline
CSR-PABG-48&
\begin{minipage}{12cm}
We clarified in Section~\ref{subsec:libgscsp_data} the mutations to be applied to the payload, and how they would be detected by the existing test suite.
\end{minipage}\\
\hline
CSR-PABG-49&
\begin{minipage}{12cm}
We added more details about the provided test suite and the scope of libparam in FAQAS.
\end{minipage}\\
\hline
CSR-PABG-50&
\begin{minipage}{12cm}
\TODO{I did not change the text for this comment, below there is my answer.}
The code coverage reported in Table~\ref{table:gslibutil_coverage} considers all the 201 test cases for all the source code of libutil.
\end{minipage}\\
\hline
CSR-PABG-51&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-52&
\begin{minipage}{12cm}
\end{minipage}\\
\hline
CSR-PABG-53&
\begin{minipage}{12cm}
\end{minipage}\\
\hline


%Author: Pedro Barrios Subject: Sticky Note Date: 28/02/2020, 09:18:11
%Comment #4:
%It is perhaps interesting to add a chapter with some basic definitions?
%e.g. equivalent mutant, redundant mutant, mutation score, killed mutant, live mutant, weak mutation, ...
%Author: Pedro Barrios Subject: Sticky Note Date: 28/02/2020, 09:18:18
%Comment #5:
%Please, consider to add more examples.

% \bottomrule                                                             
\end{longtable}
\normalsize

\clearpage